Lecroy Corp (LCRY) Matches Q2 EPS Views, Guides Q3 and FY
Tweet
Share
E-mailGet Alerts LCRY Hot Sheet
Price: $14.31 --0%
Financial Fact:
Income (loss) before income taxes: 1.66M
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Income (loss) before income taxes: 1.66M
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Lecroy Corp (NASDAQ: LCRY) reported Q2 EPS of $0.30, in-line with the analyst estimate of $0.30. Revenue for the quarter came in at $51.1 million versus the consensus estimate of $50.68 million.
Lecroy Corp sees Q3 2012 EPS of $0.25-$0.27, versus the consensus of $0.30. Lecroy Corp sees Q3 2012 revenue of $47-$49 million, versus the consensus of $50.33 million.
Lecroy Corp sees FY2012 EPS of $1.10-$1.12, versus the consensus of $1.19. Lecroy Corp sees FY2012 revenue of ~$200 million, versus the consensus of $202.58 million.
For earnings history and earnings-related data on Lecroy Corp (LCRY) click here.
Lecroy Corp sees Q3 2012 EPS of $0.25-$0.27, versus the consensus of $0.30. Lecroy Corp sees Q3 2012 revenue of $47-$49 million, versus the consensus of $50.33 million.
Lecroy Corp sees FY2012 EPS of $1.10-$1.12, versus the consensus of $1.19. Lecroy Corp sees FY2012 revenue of ~$200 million, versus the consensus of $202.58 million.
For earnings history and earnings-related data on Lecroy Corp (LCRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
